Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

*UPDATED*Bonus Short - The Saga Continues with Remdesivir and Hydroxychloroquine

Free Episode

*UPDATED*The Saga Continues with Remdesivir and Hydroxychloroquine

Salim Rezaie, MD
00:00
09:19

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Tags COVID19 · infectious disease · pharmacology

*Editor's note: As of June 4, 2020, The Lancet article by Mehra MR et al has been retracted. (https://www.thelancet.com/lancet/article/s0140673620313246)

In this Hippo Education short, Dr.Salim Rezaie from REBEL EM and Lit Matters critically appraises two papers published on Friday May 22nd, 2020.  He discusses what the evidence shows for both remdesivir & hydroxychloroquine/chloroquine as effective treatment or prophylaxis for COVID-19.

Released 6/10/20


References:

  1. Beigel JH et al. Remdesivir for the Treatment of COVID-19 – Preliminary Report. NEJM 2020.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.